Interactions of cyclosporine and some derivatives with model membranes: binding and ion permeability changes.
Fahr
A
A
Sandoz Pharma AG, Basel, Switzerland.
Nimmerfall
F
F
Wenger
R
R
D000327:Adsorption; D000001:Calcimycin; D016572:Cyclosporine / Q000737:chemistry* / Q000378:metabolism; D003524:Cyclosporins / Q000737:chemistry* / Q000378:metabolism; D005454:Fluorescence Polarization; D007165:Immunosuppression Therapy; D007700:Kinetics; D008081:Liposomes; D015394:Molecular Structure; D010713:Phosphatidylcholines; D012964:Sodium; D013329:Structure-Activity Relationship; D014634:Valinomycin
D003524:Cyclosporins; D008081:Liposomes; D010713:Phosphatidylcholines; D014634:Valinomycin; D000001:Calcimycin; D016572:Cyclosporine; D012964:Sodium; C017251:1,2-oleoylphosphatidylcholine